Axa’s NCI, Inc. NCIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-37,842
| Closed | -$798K | – | 1403 |
|
|
2017
Q2 | $798K | Buy |
37,842
+4,500
| +13% | +$77.2K | ﹤0.01% | 973 |
|
|
2017
Q1 | $502K | Hold |
33,342
| – | – | ﹤0.01% | 1076 |
|
|
2016
Q4 | $465K | Hold |
33,342
| – | – | ﹤0.01% | 1065 |
|
|
2016
Q3 | $386K | Buy |
33,342
+2,673
| +9% | +$33.4K | ﹤0.01% | 1060 |
|
|
2016
Q2 | $431K | Buy |
30,669
+19,900
| +185% | +$274K | ﹤0.01% | 1037 |
|
|
2016
Q1 | $151K | Buy |
10,769
+4,758
| +79% | +$64.6K | ﹤0.01% | 1176 |
|
|
2015
Q4 | $82K | Hold |
6,011
| – | – | ﹤0.01% | 1262 |
|
|
2015
Q3 | $80K | Sell |
6,011
-2,800
| -32% | -$35.2K | ﹤0.01% | 1323 |
|
|
2015
Q2 | $91K | Buy |
8,811
+2,101
| +31% | +$22K | ﹤0.01% | 1292 |
|
|
2015
Q1 | $67K | Hold |
6,710
| – | – | ﹤0.01% | 1349 |
|
|
2014
Q4 | $69K | Buy |
6,710
+5,351
| +394% | +$56.3K | ﹤0.01% | 1339 |
|
|
2014
Q3 | $13K | Buy |
+1,359
| New | +$12.7K | ﹤0.01% | 1413 |
|
Axa's NCIT Position: Q3 2017 in Review
Axa sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 37,842 shares — an estimated $798K sold.
Axa first reported a position in NCIT in Q3 2014 and held it in 12 quarters. The position peaked at $798K in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.
- Axa reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
- Axa sold 37,842 NCI, Inc. shares in Q3 2017, an estimated $798K.
- Axa first reported a position in NCI, Inc. in Q3 2014 and held it in 12 quarters.
- Axa's NCI, Inc. position peaked at $798K in Q2 2017.
- 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.
Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.